Spiral Therapeutics Announces First Closing of a Series A Financing and Begins Phase 1 Trial of New Hearing Loss Drug

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2BsvCHf
via IFTTT